Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 192, 108598
Abstract
No abstract availableKeywords
Funding Information
- Beatrice & Samuel A Seaver Foundation
- National Institute on Drug Abuse
- Brain and Behavior Research Foundation
This publication has 210 references indexed in Scilit:
- Immune system inflammation in cocaine dependent individuals: implications for medications developmentHuman Psychopharmacology: Clinical and Experimental, 2012
- Drug-Evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit RemodelingNeuron, 2011
- Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequencesNeuroscience, 2010
- Evidence that opioids may have toll-like receptor 4 and MD-2 effectsBrain, Behavior, and Immunity, 2010
- The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine releaseBrain, Behavior, and Immunity, 2009
- Minocycline affects cocaine sensitization in miceNeuroscience Letters, 2009
- Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)Brain, Behavior, and Immunity, 2009
- Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesiaBrain, Behavior, and Immunity, 2008
- Proinflammatory cytokines oppose opioid-induced acute and chronic analgesiaBrain, Behavior, and Immunity, 2008
- An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune SystemCell, 2005